Pieris Pharmaceuticals: Q3 Earnings Snapshot
In this article:
BOSTON (AP) — BOSTON (AP) — Pieris Pharmaceuticals Inc. (PIRS) on Tuesday reported a loss of $10.8 million in its third quarter.
The Boston-based company said it had a loss of 11 cents per share.
The biopharmaceutical company posted revenue of $19.5 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PIRS at https://www.zacks.com/ap/PIRS
